High-purity active ingredients and essential cosmetic raw materials engineered for precision formulations.
In modern dermatology and industrial cosmeceutical manufacturing, hyperpigmentation, melasma, inflammatory erythema, and acne vulgaris represent persistent global skin challenges. The market has shifted dramatically from legacy harsh chemical agents toward multi-target, highly biocompatible active ingredients. At the forefront of this industrial transformation are Tranexamic Acid (trans-4-(Aminomethyl)cyclohexanecarboxylic acid, CAS 1197-18-8) and Azelaic Acid (1,7-heptanedicarboxylic acid, CAS 123-99-9).
As premier active ingredients manufactured at scale in China, the synergy between synthetic antifibrinolytic analogues and natural dicarboxylic acids provides cosmetic chemistry laboratories and pharmaceutical formulators with unmatched therapeutic efficacy. China's fine chemical sector has evolved from raw chemical batch production into high-precision, green-synthesis bio-manufacturing, securing over 65% of global market distribution for pharmaceutical-grade active raw materials.
Understanding the biological pathways of Tranexamic Acid and Azelaic Acid in clinical and commercial formulations.
Mechanistic Action: Structurally similar to lysine, Tranexamic Acid reversibly blocks the lysine-binding sites on plasminogen molecules. This inhibits keratinocyte-plasminogen interaction, downregulating ultraviolet-induced single-chain urokinase plasminogen activator (sc-uPA).
Cosmeceutical Result: Suppresses prostaglandin E2 (PGE2) synthesis and prevents inflammatory melanogenesis triggered by post-inflammatory hyperpigmentation (PIH) and UV exposure.
Mechanistic Action: Functions as a competitive inhibitor of tyrosinase within hyperactive melanocytes while sparing normal tissue. Additionally, it exhibits potent anti-bacterial activity by inhibiting microbial protein synthesis in Cutibacterium acnes.
Cosmeceutical Result: Normalizes follicular keratinization, suppresses 5-alpha reductase activity, and eliminates intracellular reactive oxygen species (ROS) in acneic skin.
Mechanistic Action: Combining Tranexamic Acid (vasculature-mediated & paracrine pathway suppression) with Azelaic Acid (direct tyrosinase inhibition & anti-comedogenic exfoliation) creates a comprehensive multi-layered therapy.
Cosmeceutical Result: Clinically proven to accelerate stubborn melasma clearance, eliminate recalcitrant acne scars, and minimize post-procedure erythema without inducing rebound hyperpigmentation.
Factory-certified parameters for bulk procurement and international standard compliance.
| Chemical Property / Parameter | Tranexamic Acid (CAS 1197-18-8) | Azelaic Acid (CAS 123-99-9) | Testing Standard / Protocol |
|---|---|---|---|
| Chemical Appearance | White crystalline powder | White to light yellow fine powder/granules | Visual / Organoleptic Inspection |
| Assay Purity (HPLC) | ≥ 99.5% (Pharmaceutical Grade) | ≥ 99.0% (Industrial & Cosmetic Grade) | High Performance Liquid Chromatography |
| Melting Point Range | > 300 °C (Decomposition) | 109.0 °C – 112.0 °C | Capillary Melting Point Method |
| Solubility Profile | Freely soluble in water, insoluble in ethanol | Slightly soluble in cold water, soluble in hot water/alcohol | USP / EP Dissolution Testing |
| pH Value (Solution) | 7.0 – 8.0 (5% aqueous solution) | 4.0 – 5.0 (Saturated solution) | Digital Potentiometric pH Meter |
| Heavy Metals (as Pb) | ≤ 10 ppm | ≤ 10 ppm | Inductively Coupled Plasma (ICP-MS) |
| Loss on Drying | ≤ 0.5% | ≤ 0.5% | Gravimetric Thermal Analysis |
| Regulatory Compliance | USP / BP / EP / CP / REACH | REACH / Cosmetics Europe / US FDA DMF | ISO 9001:2015 Verified |
Established in 2010 and headquartered in the prestigious Chemical Industry Park of Jinan City, Shandong Province, JIMPOCHEM CO., LTD covers a state-of-the-art industrial footprint exceeding 500 acres. As a designated professional chemical raw material manufacturer, we seamlessly integrate advanced scientific research and development, large-scale industrial production, international market distribution, and specialized technical support services.
Our core manufacturing focus spans high-end fine chemicals, specialty organic synthesis intermediates, and premium cosmetic raw materials. Operating under strict global quality frameworks, JIMPOCHEM holds ISO 9001 Quality System Certification and ISO 14001 Environmental Management Certification, establishing an unshakeable benchmark for batch-to-batch consistency, traceability, and supply resilience.
Leveraging strategic raw material procurement channels in East China, our modern production base utilizes intelligent DCS dynamic control systems to automate chemical reactions. This ensures seamless scalability from multi-ton commercial orders to tailor-made customer specifications.
Under our core ethos "Quality is the lifeline of an enterprise," every incoming lot undergoes stringent HPLC, GC-MS, and ICP-MS testing. Our end-to-end QR batch tracking code guarantees full raw material provenance and regulatory safety.
In response to global carbon-neutral mandates, JIMPOCHEM employs low-emission catalytic processes and closed-loop wastewater purification systems. Our environmentally conscious manufacturing empowers downstream clients to hit ESG compliance effortlessly.
Deploying targeted active ingredients across diverse consumer and industrial chemical matrices.
Tranexamic acid serves as a cornerstone ingredient in topical post-procedure serums. It calms thermal micro-injuries, prevents post-laser hyperpigmentation, and stabilizes vascular reactivity following fractional IPL or microneedling therapies.
Azelaic Acid at concentrations between 10% and 20% forms the gold standard for clinical topical gels treating papulopustular rosacea, comedonal acne, and persistent post-inflammatory erythema (PIE).
In everyday brightening skin care regimes, micro-encapsulated combinations of Tranexamic Acid with stable Vitamin C derivatives (such as Ascorbyl Glucoside AA2G) provide daily protection against oxidative stress and uneven skin tones.
Beyond topical cosmetics, our fine synthesis facilities produce basic chemical precursors and solvents essential for synthetic drug formulation, active pharmaceutical ingredient (API) building blocks, and medical preparations.
Incorporating Azelaic acid derivatives into anti-dandruff shampoos and scalp serums effectively balances seborrheic flora, regulates sebum production, and reduces micro-inflammation of follicular units.
Our dedicated formulation engineering team provides customized solvent phase adjustments, emulsifier compatibility testing, and structural solubilization solutions tailored to client product lines.
The industrial landscape for chemical actives is moving toward enhanced transdermal bio-availability, minimal skin irritation, and carbon-neutral synthetic pathways. JIMPOCHEM’s R&D center, in partnership with leading chemical institutes, is pioneering three critical technological frontiers:
Take a visual tour inside our Jinan industrial park, advanced QC laboratories, automated reaction workshops, and warehousing infrastructure.
Addressing key scientific, regulatory, and commercial procurement inquiries from global formulators and chemical purchasers.
Explore our full line of fine chemicals, active cosmetic ingredients, and organic synthesis intermediates.
Explore our specialized chemical divisions designed for global B2B procurement.
High-purity ingredients optimized for cosmetics, skincare, perfumes, hand sanitizers, body washes, and oral care formulations.
Specialty solvent matrices, polymer stabilizers, and custom syntheses for industrial applications.
Active pharmaceutical ingredients (APIs), excipients, buffers, and specialty biochemical precursors.
JIMPOCHEM